THE DUAL DIAGNOSIS: SCHIZOPHRENIA AND SUBSTANCE ABUSE
- Authors: Sivolap Y.P1, Yanushkevich M.V1, Savchenkov V.A1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol XLIX, No 2 (2017)
- Pages: 57-60
- Section: Articles
- URL: https://journal-vniispk.ru/1027-4898/article/view/14070
- DOI: https://doi.org/10.17816/nb14070
- ID: 14070
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Yury P Sivolap
I.M. Sechenov First Moscow State Medical University
Email: yura-sivolap@yandex.ru
Department of Psychiatry and Addiction 119991,Trubetskaya Str., 8 (2), Moscow
Maxim V Yanushkevich
I.M. Sechenov First Moscow State Medical UniversityDepartment of Psychiatry and Addiction 119991,Trubetskaya Str., 8 (2), Moscow
Vladimir A Savchenkov
I.M. Sechenov First Moscow State Medical UniversityDepartment of Psychiatry and Addiction 119991,Trubetskaya Str., 8 (2), Moscow
References
- Менделевич В.Д. Психотические расстройства в результате употребления наркотиков: современное состояние проблемы // Наркология. 2014. №7. С. 93-100.
- Alderson H.L., Semple D.M., Blayney C. et al. Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study // Psychol-Med 2017. Vol. 3. P. 1-8.
- Balhara Y.P., Kuppili P.P., Gupta R. Neurobiology of comorbid substance use disorders and psychiatric disorders: current state of evidence // J-Addict-Nurs 2017. Vol. 28 (1). P. 11-26.
- Belli H., Ural C. The association between schizophrenia and violent or homicidal behaviour: the prevention and treatment of violent behaviour in these patients // West-Indian-Med-J. 2012. Vol. 61 (5). P. 538-543.
- Castle D.J., Buckley P.F. Schizophrenia. Second Revised Edition. Oxford: Oxford University Press, 2012. 132 p.
- Coentre R., Talina M.C., Góis C., Figueira M.L. Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review // Psychiatry-Res. 2017. Vol. 253. P. 240-248.
- Dervaux A., Laqueille X., Bourdel M.C. et al. Cannabis and schizophrenia: demographic and clinical correlates // Encephale. 2003. Vol. 29 (1). P. 11-17.
- Gouzoulis-Mayfrank E. Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment // Z-Kinder-Jugendpsychiatr-Psychother 2008. Vol. 36 (4). P. 245-253.
- Gouzoulis-Mayfrank E., Walter M. Schizophrenia and Addiction. In: Geert Dom Franz Moggi (Editors). Co-occurring Addictive and Psychiatric Disorders. A Practice-Based Handbook from a European Perspective. Berlin: Springer, 2015. P. 75-86.
- Kudumija Slijepcevic M., Jukic V., Novalic D. et al. Alcohol abuse as the strongest risk factor for violent offending in patients with paranoid schizophrenia // Croat-Med-J 2014. Vol. 55 (2). P. 156-162.
- Mueser K.T., Gingerich S. Treatment of co-occurring psychotic and substance use disorders // Soc-Work-Public-Health 2013. Vol. 28 (3-4). P. 424-439.
- Niemi-Pynttäri J.A., Sund R., Putkonen H. et al. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases // J-Clin-Psychiatry. 2013. Vol. 74 (1). e94-99.
- Velligan D.I., Sajatovic M., Hatch A. et al. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness // Patient-Prefer-Adherence, 2017. Vol. 11. P. 449-468.
Supplementary files
